HyQvia is a liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
HyQvia is a liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
HyQvia is a liquid medicine that is given under the skin (subcutaneously) to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
©2024 Takeda Pharmaceuticals U.S.A., Inc., 500 Kendall Street, Cambridge MA 02142. 1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. TAKEDA®, the TAKEDA Logo®, and the TAKEDA Patient Support Logo™ are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited. HYQVIA® and MYIGSOURCE™ are trademarks or registered trademarks of Baxalta Incorporated.
US-HYQ-1215v1.0 05/24
See you later!
We hate to part, but you’re now leaving this site and being redirected to a site not owned or managed by Takeda.
See you later!
We hate to part, but you're now leaving this site and being redirected.
©2024 Takeda Pharmaceuticals U.S.A., Inc., 300 Shire Way, Lexington, MA 02421. 1-877-TAKEDA-7 (1-877-825-3327). All rights reserved. TAKEDA®, the TAKEDA Logo®, and the TAKEDA Patient Support Logo™ are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited. HYQVIA® and MYIGSOURCE™ are trademarks or registered trademarks of Baxalta Incorporated.
US-HYQ-0946v1.0 04/24
See you later!
We hate to part, but you’re now leaving this site and being redirected to a site not owned or managed by Takeda.
See you later!
We hate to part, but you're now leaving this site and being redirected.